RBC raises target for Procter & Gamble stock to USD 169

Published on 10/26/2026 at 16:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

P&G kept USD 6.89-7.11 core earnings guidance. Procter & Gamble stock costs EUR 142.86 on October 26, 2026, down 0.81 percent versus Xetra close.

RBC sets USD 169 target

RBC raised its Procter & Gamble target from USD 166.00 to USD 169.00 on October 23, 2026.
Fiscal first-quarter net sales rose 4.00 percent to USD 23.3 billion, while core earnings per share increased 1.00 percent to USD 2.00.
Procter & Gamble stock costs EUR 142.86 at Lang & Schwarz on October 26, 2026 at 4:41 p.m. CEST, 0.81 percent below the Xetra close of October 23, 2026.
The stock's USD 370.2 billion market value carries a P/E of 24.05.

Procter & Gamble, US7427181091, Illustration mit AI erstellt.

RBC Capital Markets raised its Procter & Gamble price target from USD 166.00 to USD 169.00 on October 23, 2026, while keeping its Outperform rating, according to MarketScreener. The target is 5.81 percent above the USD 159.71 primary-market price at the latest quoted level. Procter & Gamble stock was trading at EUR 142.86 at Lang & Schwarz on October 26, 2026 at 4:41 p.m. CEST, down 0.81 percent versus the Xetra close of October 23, 2026 at EUR 144.02.

Quarterly sales reach USD 23.3 billion

Procter & Gamble reported fiscal first-quarter 2027 net sales of USD 23.3 billion on October 22, 2026, up 4.00 percent from USD 22.4 billion a year earlier. Diluted earnings per share rose 1.00 percent to USD 1.97, while core earnings per share increased 1.00 percent to USD 2.00, according to the company's release carried by Procter & Gamble. Operating cash flow reached USD 5.8 billion, and the company returned USD 3.9 billion through dividends and share repurchases.

Stock sits below its yearly high

The primary-market quote was USD 159.71 on October 26, 2026 at 11:50 a.m. ET. Procter & Gamble's 52-week range was USD 137.62 to USD 167.25, putting the latest price 4.51 percent below the high and 16.03 percent above the low. The market capitalization was USD 370.2 billion, and the quoted volume was 2,126,826 shares.

Valuation and cash returns

The latest quoted price carried a P/E of 24.05 and a dividend yield of 3.00 percent. For fiscal 2027, the company maintained core earnings per share guidance of USD 6.89 to USD 7.11 and all-in sales growth guidance of 2.00 percent to 4.00 percent in its October 22, 2026 release. The outlook also included a projected USD 1.4 billion after-tax commodity cost headwind.

Comparison with peers

Procter & Gamble: down 0.81 percent, P/E 24.05, market capitalization USD 370.2 billion

Colgate-Palmolive (NYSE, USD): down 1.07 percent, P/E 36.86, market capitalization USD 74.2 billion

Kimberly-Clark (NYSE, USD): down 0.47 percent, P/E 18.65, market capitalization USD 36.5 billion

What the target means for valuation

RBC's revised USD 169.00 target sits above the latest USD 159.71 primary-market quote, while the euro quotation remains below the October 23 Xetra close. The combination leaves the analyst target as the clearest fresh valuation reference for the stock.

Procter & Gamble stock was trading at EUR 142.86 at Lang & Schwarz on October 26, 2026 at 4:41 p.m. CEST, 0.81 percent below the Xetra close of October 23, 2026 at EUR 144.02. The stock was also 4.51 percent below its USD 167.25 52-week high in the primary market. The further course of trading is shown by the continuously updated real-time quote of Procter & Gamble stock.